While the benefits of shifting to decentralized clinical trials are clear, it can be hard to know where to start.
Castor advisor Craig Lipset, a recognized leader of innovation in clinical research and former Head of Clinical Innovation at Pfizer, suggests that you consider DCT technology as three separate tiers.
Learn more about these tiers and get started with DCT in 2022 with these pro tips.
- a base level to get going
- a state-of-the-art integrated space
- a full ecosystem equipped for groundbreaking research